Literature DB >> 11103042

Eradication of cryptosporidia and microsporidia following successful antiretroviral therapy.

Y M Miao1, F M Awad-El-Kariem, C Franzen, D S Ellis, A Müller, H M Counihan, P J Hayes, B G Gazzard.   

Abstract

OBJECTIVES: Incidence of opportunistic protozoal infections causing diarrheal illnesses in patients with HIV has decreased since the introduction of highly active antiretroviral therapy (HAART). The objective of this study was to determine whether the parasites, cryptosporidia, and microsporidia were effectively eradicated or only suppressed following treatment.
DESIGN: Six HIV-positive patients with diarrheal symptoms caused by cryptosporidia or microsporidia were prospectively followed up with stool samples and duodenal biopsies. Samples were taken before HAART, between 1 to 3 months, and 6 months post-HAART.
METHODS: Duodenal samples were analyzed using routine histology and transmission electron microscopy. Stool samples were analyzed by both light microscopy and polymerase chain reaction (PCR) techniques.
RESULTS: Patients who responded successfully to HAART eradicated both cryptosporidial and microsporidial organisms. Symptoms improved within 1 month of therapy but complete eradication of the organisms was only observed after 6 months of treatment.
CONCLUSIONS: AIDs-related cryptosporidiosis and microsporidiosis can be cured following successful antiretroviral therapy.

Entities:  

Mesh:

Year:  2000        PMID: 11103042     DOI: 10.1097/00042560-200010010-00006

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  30 in total

Review 1.  HIV1 and the gut in the era of highly active antiretroviral therapy.

Authors:  Esteban C Nannini; Pablo C Okhuysen
Journal:  Curr Gastroenterol Rep       Date:  2002-10

2.  The state of research for AIDS-associated opportunistic infections and the importance of sustaining smaller research communities.

Authors:  Anthony P Sinai; Edna S Kaneshiro; Honorine Ward; Louis M Weiss; Melanie T Cushion
Journal:  Eukaryot Cell       Date:  2011-12-09

3.  Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

Review 4.  Epidemiology and clinical features of Cryptosporidium infection in immunocompromised patients.

Authors:  Paul R Hunter; Gordon Nichols
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

Review 5.  The evolution of respiratory Cryptosporidiosis: evidence for transmission by inhalation.

Authors:  Jerlyn K Sponseller; Jeffrey K Griffiths; Saul Tzipori
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

6.  Emerging microsporidian infections in Russian HIV-infected patients.

Authors:  Olga I Sokolova; Anton V Demyanov; Lisa C Bowers; Elizabeth S Didier; Alexei V Yakovlev; Sergei O Skarlato; Yuliya Y Sokolova
Journal:  J Clin Microbiol       Date:  2011-03-30       Impact factor: 5.948

7.  Multiplex Real-time PCR Detection of Intestinal Protozoa in HIV-infected Children in Malawi: Enterocytozoon Bieneusi Is Common and Associated With Gastrointestinal Complaints and May Delay BMI (Nutritional Status) Recovery.

Authors:  Minke H W Huibers; Peter Moons; Nelson Maseko; Monfort B Gushu; Oluwadamilola H Iwajomo; Robert S Heyderman; Michael Boele van Hensbroek; Eric A Brienen; Lisette van Lieshout; Job C J Calis
Journal:  Pediatr Infect Dis J       Date:  2018-09       Impact factor: 2.129

Review 8.  Clinical significance of enteric protozoa in the immunosuppressed human population.

Authors:  D Stark; J L N Barratt; S van Hal; D Marriott; J Harkness; J T Ellis
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

9.  Cryptosporidium spp. Infection in Solid Organ Transplantation: The Nationwide "TRANSCRYPTO" Study.

Authors:  Fanny Lanternier; Karima Amazzough; Loic Favennec; Marie-France Mamzer-Bruneel; Hendy Abdoul; Jérome Tourret; Stéphane Decramer; Julien Zuber; Anne Scemla; Christophe Legendre; Olivier Lortholary; Marie-Elisabeth Bougnoux
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

10.  Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  Lynne M Mofenson; Michael T Brady; Susie P Danner; Kenneth L Dominguez; Rohan Hazra; Edward Handelsman; Peter Havens; Steve Nesheim; Jennifer S Read; Leslie Serchuck; Russell Van Dyke
Journal:  MMWR Recomm Rep       Date:  2009-09-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.